Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143044 |
| CAS No | NA |
| Mol.F. | C19H22N4O4 |
| Mol.Wt. | 370.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143045 |
| CAS No | NA |
| Mol.F. | C12H13N3O3 |
| Mol.Wt. | 247.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143046 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143047 |
| CAS No | NA |
| Mol.F. | C14H19N3O4 |
| Mol.Wt. | 293.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143048 |
| CAS No | NA |
| Mol.F. | C19H21N3O4 |
| Mol.Wt. | 355.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143049 |
| CAS No | NA |
| Mol.F. | C19H29N3O4 |
| Mol.Wt. | 363.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143050 |
| CAS No | NA |
| Mol.F. | C24H23N3O4 |
| Mol.Wt. | 417.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143051 |
| CAS No | NA |
| Mol.F. | C19H22N2O5 |
| Mol.Wt. | 358.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143052 |
| CAS No | NA |
| Mol.F. | C20H24N2O5 |
| Mol.Wt. | 372.42 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143053 |
| CAS No | NA |
| Mol.F. | C16H17N3O4 |
| Mol.Wt. | 315.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143054 |
| CAS No | NA |
| Mol.F. | C19H21N3O4 |
| Mol.Wt. | 355.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143055 |
| CAS No | NA |
| Mol.F. | C19H22BrN3O4 |
| Mol.Wt. | 436.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143056 |
| CAS No | NA |
| Mol.F. | C24H34N4O8 |
| Mol.Wt. | 506.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143057 |
| CAS No | NA |
| Mol.F. | C37H52N6O9 |
| Mol.Wt. | 724.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143058 |
| CAS No | NA |
| Mol.F. | C8H12F3N3O4 |
| Mol.Wt. | 271.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143059 |
| CAS No | NA |
| Mol.F. | C20H26F3N3O6 |
| Mol.Wt. | 461.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |